ALT Med- Budesonide.pdf - ACTIVE LEARNING TEMPLATE...

This preview shows page 1 out of 1 page.

Unformatted text preview: ACTIVE LEARNING TEMPLATE: Medication Andreja D. Wilson STUDENT NAME______________________________________ Budesonide MEDICATION___________________________________________________________________________ REVIEW MODULE CHAPTER____________ CATEGORY CLASS__Corticosteroids _____________________________________________________________________ PURPOSE OF MEDICATION Expected Pharmacological Action Potent, locally acting anti-inflammatory and immune modifier. Therapeutic Use Nebulization—Maintenance treatment and prophylactic therapy of CF. Oral inhalation—Chronic control of persistent bronchial constriction. May decrease requirement for or eliminate use of systemic corticosteroids over time Complications CNS: headache.Derm: rash. EENT: otitis media, dysphonia, epistaxis, oropharyngeal fungal infections, pharyngitis, rhinitis, sinusitis. Resp: bronchospasm, cough. GI: abdominal pain, diarrhea, dyspepsia, gastroenteritis, nausea, vomiting. Endo: adrenal suppression (high dose, long-term therapy only), decreased growth in children, weight gain. MS: back pain. Misc: ANAPHYLAXIS, flu-like syndrome. Medication Administration Inhaln (Adults): — 180– 360 mcg twice daily (not to exceed 720 mcg twice daily). Inhaln (Children 6 yr): — 180– 360 mcg twice daily (not to exceed 360 mcg twice daily). Respules: Inhaln (Children 1– 8 yr): Previously on bronchodilators alone– 0.5 mg once daily or 0.25 mg twice daily (not to exceed 0.5 mg/day); Previously on otherinhaled corticosteroids—0.5 mg once daily or 0.25 mg twice daily (not to exceed 1 mg/ day); Previously on oral corticosteroids—1 mg once daily or 0.5 mg twice daily (not to exceed 1 mg/day). Contraindications/Precautions Hypersensitivity; Active untreated infections; Diabetes or glaucoma; Underlying immunosuppression; Systemic corticosteroid therapy; Interactions Strong CYP3A4 inhibitors, including ritonavir, atazanavir, clarithromycin, indinavir, itraconazole, ketoconazole, nefazodone, nelfinavir,saquinavir, and telithromycin inc. metabolism and inc. levels of budesonide. Nursing Interventions -Monitor respiratory status and lung sounds. -Assess pulmonary function tests periodically during and after treatment -Assess patients changing from systemic corticosteroids to inhalation corticosteroids for signs of adrenal insufficiency -Lab Test Considerations: Periodic adrenal function tests may be ordered to assess degree of hypothalamic-pituitary-adrenal (HPA) axis suppression in chronic therapy. Client Education Evaluation of Medication Effectiveness Management/ improvement of the symptoms of CF ACTIVE LEARNING TEMPLATES -Advise patient to notify health care professional if sore throat/mouth/sx of anaphylaxis -Rinse mouth with water after treatment -Female patients to notify health care professional if pregnancy is planned or suspected or if breast feeding -Allow at least 1 min between inhalations of med. Do not shake inhaler or use with spacer.Wait 5 min between use of bronchodilator and use of corticosteroid Therapeutic Procedure  A7 ...
View Full Document

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture